Table 2.
Gene ID | Protein Family/ Subfamily |
Annotated Accession (NCBI/Uniprot) | Species | Coverage A (%) |
Transcript B Abundance (%) |
---|---|---|---|---|---|
Three-finger toxins (3FTX) | 87.54% | ||||
Short-chain 3FTX: Short α-NTX (SNTX) | 1.78% | ||||
NN-3FTX01 | Short neurotoxin 2 | P62376 | Hydrophis cyanocinctus | 13–79 | 0.11% |
NN-3FTX02 * | Cobrotoxin | P60770 | Naja atra | 1–82 (98.80) | 0.69% |
NN-3FTX03 * | Cobrotoxin-b | P80958 | Naja atra | 1–82 (100) | 0.97% |
Short-chain 3FTX: Orphan Group I | 0.61% | ||||
NN-3FTX04 | Neurotoxin-like protein NTL2 | Q9W717 | Naja atra | 1–75 | 0.61% |
Short-chain 3FTX: Muscarinic toxin-like protein (MTLP) | 1.37% | ||||
NN-3FTX05 * | Neurotoxin homolog NL1 | Q9DEQ3 | Naja atra | 6–86 (94.19) | 0.96% |
NN-3FTX06 | Muscarinic toxin-like protein 2 | P82463 | Naja kaouthia | 1–46 | 0.41% |
NN-3FTX07 | Haditoxin | A8N286 | Ophiophagus hannah | 36–84 | 0.001% |
Short-chain 3FTX: Cytotoxin/cardiotoxin (CTX) | 77.33% | ||||
NN-3FTX08 * | Cytotoxin 5 | Q98961 | Naja atra | 1–81 (100) | 77.33% |
Long-chain 3FTX: Long α-NTX (LNTX) | 1.10% | ||||
NN-3FTX09 * | Long neurotoxin 7 | O42257 | Naja sputatrix | 12–88 (97.78) | 1.00% |
NN-3FTX10 | Long neurotoxin 1 | Q8UW29 | Hydrophis hardwickii | 12–91 | 0.01% |
NN-3FTX11 | Long neurotoxin-like OH-31 | Q53B55 | Ophiophagus hannah | 20–59 | 0.08% |
NN-3FTX12 | Long neurotoxin-like OH-31 | Q53B55 | Ophiophagus hannah | 5–59 | 0.003% |
Non-conventional 3FTX: Weak neurotoxin (WTX) | 5.35% | ||||
NN-3FTX13 | Probable weak neurotoxin NNAM1 | Q9YGI2 | Naja atra | 15–86 | 5.35% |
Phospholipase A2 (PLA2) | 2.08% | ||||
NN-PLA01 | Basic phospholipase A2 | P00610 | Hydrophis schistosus | 23–119 | 0.01% |
NN-PLA02 | Basic phospholipase A2 | P00610 | Hydrophis schistosus | 23–119 | 0.002% |
NN-PLA03 | Acidic phospholipase A2 57 | Q8UW31 | Hydrophis hardwickii | 51–135 | 0.01% |
NN-PLA04 * | Acidic phospholipase A2 2 | P00597 | Naja kaouthia | 1–146 (100) | 2.05% |
NN-PLA05 | Basic phospholipase A2 73 | Q8UW30 | Hydrophis hardwickii | 1–56 | 0.01% |
Snake venom metalloproteinase (SVMP) | 3.80% | ||||
NN-SVMP01 | Scutatease-1 | B5KFV7 | Notechis scutatus | 337–388 | 0.04% |
NN-SVMP02 | Zinc metalloproteinase mocarhagin | Q10749 | Naja mossambica | 502–568 | 0.03% |
NN-SVMP03 | Zinc metalloproteinase mocarhagin | Q10749 | Naja mossambica | 191–241 | 0.03% |
NN-SVMP04 | Zinc metalloproteinase mocarhagin | Q10749 | Naja mossambica | 143–195 | 0.03% |
NN-SVMP05 | Zinc metalloproteinase-disintegrin cobrin | Q9PVK7 | Naja kaouthia | 159–499 | 0.27% |
NN–SVMP06 | Zinc metalloproteinase-disintegrin cobrin | Q9PVK7 | Naja kaouthia | 159–600 | 0.16% |
NN-SVMP07 | Zinc metalloproteinase-disintegrin cobrin | Q9PVK7 | Naja kaouthia | 159–600 | 0.13% |
NN-SVMP08 | Zinc metalloproteinase-disintegrin atrase-B | D6PXE8 | Naja atra | 322–369 | 0.01% |
NN-SVMP09 | Zinc metalloproteinase-disintegrin atrase-A | D5LMJ3 | Naja atra | 456–607 | 0.10% |
NN-SVMP10 | Zinc metalloproteinase-disintegrin atrase-A | D5LMJ3 | Naja atra | 456–607 | 0.10% |
NN-SVMP11 | Zinc metalloproteinase-disintegrin atrase-A | D5LMJ3 | Naja atra | 456–607 | 0.15% |
NN-SVMP12 | Zinc metalloproteinase-disintegrin atrase-A | D5LMJ3 | Naja atra | 403–607 | 0.13% |
NN-SVMP13 | Zinc metalloproteinase-disintegrin atrase-A | D5LMJ3 | Naja atra | 403–607 | 0.17% |
NN-SVMP14 | Zinc metalloproteinase-disintegrin atrase-A | D5LMJ3 | Naja atra | 456–607 | 0.28% |
NN-SVMP15 | Zinc metalloproteinase-disintegrin atrase-A | D5LMJ3 | Naja atra | 1–229 | 1.25% |
NN-SVMP16 | Hemorrhagic metalloproteinase-disintegrin kaouthiagin | P82942 | Naja kaouthia | 6–64 | 0.03% |
NN-SVMP17 | Zinc metalloproteinase-disintegrin-like atragin | D3TTC2 | Naja atra | 527–613 | 0.80% |
NN-SVMP18 | Hemorrhagic metalloproteinase-disintegrin kaouthiagin | P82942 | Naja kaouthia | 130–201 | 0.07% |
Cysteine-rich secretory protein (CRISP) | 0.35% | ||||
NN-CRISP01 * | Natrin-1 | Q7T1K6 | Naja atra | 1–239 (100) | 0.35% |
Snake venom serine protease (SVSP) | 1.56% | ||||
NN-SVSP01 * | Serine protease harobin | Q5MCS0 | Hydrophis hardwickii | 1–265 (96.60) | 1.56% |
NN-SVSP02 | Serine protease HTRA1 | V8NGT0 | Ophiophagus hannah | 79–304 | 0.001% |
NN-SVSP03 * | Serine protease 23 | V8N8N4 | Ophiophagus hannah | 8–372 (98.12) | 0.001% |
Cobra venom factor (CVF) | 0.26% | ||||
NN-CVF01 | Cobra venom factor | Q91132 | Naja kaouthia | 1586–1642 | 0.13% |
NN-CVF02 * | Cobra venom factor | Q91132 | Naja kaouthia | 1–1592 (96.96) | 0.10% |
NN-CVF03 | Cobra venom factor | Q91132 | Naja kaouthia | 1197–1592 | 0.02% |
NN-CVF04 | Cobra venom factor | Q91132 | Naja kaouthia | 1–640 | 0.01% |
Kunitz-type serine protease inhibitor (KSPI) | 0.50% | ||||
NN-KSPI01 * | Putative Kunitz-type serine protease inhibitor | B2BS84 | Austrelaps labialis | 1–252 (98.81) | 0.02% |
NN-KSPI02 * | Kunitz-type protease inhibitor | U3FZD6 | Micrurus fulvius | 1–511 (99.61) | 0.004% |
NN-KSPI03 | Protease inhibitor 3 | C1IC51 | Walterinnesia aegyptia | 1–67 | 0.17% |
NN-KSPI04 | Kunitz-type serine protease inhibitor NACI | Q5ZPJ7 | Naja atra | 43–81 | 0.30% |
Phosphodiesterase (PDE) | 0.08% | ||||
NN-PDE01 * | Snake venom phosphodiesterase | A0A2D0TC04 | Naja atra | 21–850 (97.65) | 0.08% |
5’-Nucleotidase (5’-NUC) | 0.06% | ||||
NN-NUC01 * | Ecto-5’-nucleotidase | A0A194AS98 | Micrurus tener | 1–569 (99.13) | 0.05% |
NN-NUC02 * | Ecto-5’-nucleotidase | A0A194AS98 | Micrurus tener | 1–536 (93.38) | 0.008% |
NN-NUC03 * | Ecto-5’-nucleotidase | A0A194AS98 | Micrurus tener | 1–536 (93.38) | 0.004% |
NN-NUC04 | 5’ nucleotidase | A6MFL8 | Demansia vestigiata | 134–559 | 0.001% |
Acetylcholinesterase (AChE) | 0.01% | ||||
NN-ACHE01 * | Acetylcholinesterase | Q92035 | Bungarus fasciatus | 1–566 (95.55) | 0.004% |
NN-ACHE02 | Acetylcholinesterase | Q92035 | Bungarus fasciatus | 1–566 (95.55) | 0.002% |
Hyaluronidase (HYA) | 0.002% | ||||
NN-HYA01 | Hyaluronidase | V8PHI0 | Ophiophagus hannah | 26–71 | 0.001% |
NN-HYA02 | Hyaluronidase | A0A2D4JS30 | Micrurus lemniscatus lemniscatus | 89–208 | 0.0005% |
NN-HYA03 | Hyaluronidase | A0A2D4JS30 | Micrurus lemniscatus lemniscatus | 27–91 | 0.0003% |
NN-HYA04 * | Hyaluronidase | A0A194APD1 | Micrurus tener | 1–440 (98.43) | 0.0003% |
Nerve growth factor (NGF) | 2.88% | ||||
NN-NGF01 * | Venom nerve growth factor 2 | Q5YF89 | Naja sputatrix | 1–241 (100) | 2.88% |
Vespryn (VES) | 0.04% | ||||
NN-VES01 * | Ohanin | P83234 | Ophiophagus hannah | 1–181 (100) | 0.03% |
NN-VES02 * | Ohanin | P83234 | Ophiophagus hannah | 1–181 (100) | 0.02% |
Vascular endothelial growth factor (VEGF) | 0.001% | ||||
NN-VEGF01 * | Vascular endothelial growth factor 1 | U3F558 | Micrurus fulvius | 1–142 (95.95) | 0.001% |
NN-VEGF02 * | Vascular endothelial growth factor 1 | U3F558 | Micrurus fulvius | 1–142 (95.95) | 0.0003% |
Dipeptidyl peptidase IV (DPP IV) | 0.02% | ||||
NN-DPP01 | Dipeptidyl peptidase 4 | V8P9G9 | Ophiophagus hannah | 0.02% | 0.02% |
Phospholipase B (PLB) | 0.01% | ||||
NN-PLB01 * | Phospholipase-B 81 | F8J2D3 | Drysdalia coronoides | 1–553 (100) | 0.01% |
NN-PLB02 | Phospholipase B-like | V8NLQ9 | Ophiophagus hannah | 146–196 | 0.001% |
Snake C-type lectin (SNACLEC) | 0.17% | ||||
NN-SNAC01 * | C-type lectin BfL-1 | Q90WI8 | Bungarus fasciatus | 1–158 (100) | 0.06% |
NN-SNAC02 * | C-type lectin BfL-1 | Q90WI8 | Bungarus fasciatus | 1–148 (98.67) | 0.11% |
NN-SNAC03 | Venom C-type lectin mannose binding isoform 1 variant 3 | D2YVK0 | Tropidechis carinatus | 57–158 | 0.001% |
Cystatin (CYS) | 0.01% | ||||
NN-CYS01 | Cystatin | E3P6P4 | Naja kaouthia | 0.01% | 0.01% |
Aminopeptidase (AP) | 0.004% | ||||
NN-AP01 * | Aminopeptidase | U3FZS8 | Micrurus fulvis | 1–992 (98.29) | 0.003% |
NN-AP02 * | Aminopeptidase | U3FZS8 | Micrurus fulvius | 1–992 (98.29) | 0.001% |
Waprin (WA) | 0.001% | ||||
NN-WAP01 | Waprin-Phi3 | A7X4M7 | Philodryas olfersii | 33–80 | 0.001% |
Natriuretic peptide (NP) | 0.55% | ||||
NN-NP01 | Natriuretic peptide Na-NP | D9IX97 | Naja atra | 34–77 | 0.41% |
NN-NP02 | Natriuretic peptide Na-NP | D9IX97 | Naja atra | 115–165 | 0.08% |
NN-NP03 | Natriuretic peptide Na-NP | D9IX97 | Naja atra | 25–80 | 0.06% |
L-amino acid oxidase (LAAO) | 0.08% | ||||
NN-LAAO01 | L-amino-acid oxidase | Q4JHE3 | Oxyuranus scutellatus scutellatus | 1–517 | 0.04% |
NN-LAAO02 | L-amino-acid oxidase | Q4JHE3 | Oxyuranus scutellatus scutellatus | 1–517 | 0.02% |
NN-LAAO03 | L-amino-acid oxidase | Q4JHE3 | Oxyuranus scutellatus scutellatus | 1–517 | 0.02% |
* Indicates full-length transcripts of NN-SL with >90% coverage to the annotated sequence. A indicates the length of coverage of toxin sequence when compared to the annotated sequence, and the value in bracket refers to the % coverage of full-length transcript of NN-SL. B Transcript abundance (in %) was based on FPKM (fragments per kilobase of transcript per million mapped reads) of toxin genes in NN-SL.